From 25 to 29 September INOVOTION will make a stop in Boston on its 2017 road trip to the United States. Our company will present its unique in vivo technology for efficacy and toxicity testing of oncology drug candidates.

As part of the Business France delegation, INOVOTION will first present its in vivo approach to drug discovery companies at BioPharm America 2017. It will then visit several Big Pharma and renowned biotech in Boston region, including Takeda, Pfizer, Moderna, and Johnson & Johnson Innovation centre.

Jean Viallet, the CEO of INOVOTION, inventor of our fast, sensitive and reliable in vivo approach will be present in Boston. Use his presence in Boston to your best advantage to discover how our platform can meet your needs in drug discovery.

To set up a meeting or to request our presentation, please contact us without delay at romain.gret@inovotion.com.